{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:52:40Z","timestamp":1774864360489,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109709","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:11:55Z","timestamp":1772151115000},"page":"109709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel phenylamino pyrimidine derivatives as potent and selective inhibitors of ABL1 tyrosine kinase for targeted anticancer therapy"],"prefix":"10.1016","volume":"174","author":[{"given":"Dilpreet","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Kciuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Kontek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumesh Chandra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109709_bb0005","doi-asserted-by":"crossref","unstructured":"X. Yu, H. Zhao, R. Wang, Y. Chen, X. Ouyang, W. Li, Y. Sun, A. Peng, Cancer epigenetics: from laboratory studies and clinical trials to precision medicine, Cell Death Discov. 2024 10:1 10 (2024) 1\u201312. doi:https:\/\/doi.org\/10.1038\/s41420-024-01803-z.","DOI":"10.1038\/s41420-024-01803-z"},{"key":"10.1016\/j.bioorg.2026.109709_bb0010","doi-asserted-by":"crossref","first-page":"24830","DOI":"10.1021\/acs.jmedchem.5c02894","article-title":"Fragment-to-lead medicinal chemistry publications in 2024: a tenth annual perspective","volume":"68","author":"Twigg","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0015","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bmcl.2019.04.009","article-title":"Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy","volume":"29","author":"Wang","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109709_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2008.06.039","article-title":"Gallic acid-based indanone derivatives as anticancer agents q","author":"Saxena","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109709_bb0030","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109709_bb0035","article-title":"Receptor tyrosine kinases: biological functions and anticancer targeted therapy","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.bioorg.2026.109709_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109709_bb0045","doi-asserted-by":"crossref","unstructured":"C. Tomuleasa, A.B. Tigu, R. Munteanu, C.S. Moldovan, D. Kegyes, A. Onaciu, D. Gulei, G. Ghiaur, H. Einsele, C.M. Croce, Therapeutic advances of targeting receptor tyrosine kinases in cancer, Signal Transduct. Target. Ther. 2024 9:1 9 (2024) 1\u201351. doi:https:\/\/doi.org\/10.1038\/s41392-024-01899-w.","DOI":"10.1038\/s41392-024-01899-w"},{"key":"10.1016\/j.bioorg.2026.109709_bb0050","article-title":"Receptor tyrosine kinases: biological functions and anticancer targeted therapy","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.bioorg.2026.109709_bb0055","doi-asserted-by":"crossref","first-page":"25324","DOI":"10.1021\/acs.jmedchem.5c02307","article-title":"Discovery and development of a small-molecule inhibitor targeting the GAS41 YEATS domain in nonsmall cell lung Cancer","volume":"68","author":"Listunov","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140125","article-title":"Discovery of novel thiophene [2,3-D] pyrimidine\u2013thiazole derivative as promising MNK inhibitor to treat breast cancer","volume":"1321","author":"Zhu","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109709_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13020184","article-title":"Protein tyrosine kinases: their roles and their targeting in Leukemia","volume":"13","author":"Bhanumathy","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.109709_bb0070","first-page":"80","article-title":"From discovery of tyrosine phosphorylation to targeted cancer therapies: the 2018 Tang prize in biopharmaceutical science","volume":"42","author":"Yu","year":"2019","journal-title":"Biom. J."},{"key":"10.1016\/j.bioorg.2026.109709_bb0075","unstructured":"G.A. Patani, E.J. Lavoie, Bioisosterism: A Rational Approach in Drug Design, (n.d.)."},{"key":"10.1016\/j.bioorg.2026.109709_bb0080","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0085","series-title":"Dassault Syst\u00e8mes, [Biovia Discovery Studio], [2023 Client], San Diego: Dassault Syst\u00e8mes, [2024]","author":"BIOVIA","year":"2024"},{"key":"10.1016\/j.bioorg.2026.109709_bb0090","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/acs.jmedchem.0c02044","article-title":"Structure-enabled discovery of novel macrocyclic inhibitors targeting glutaminase 1 allosteric binding site","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bmcl.2018.12.065","article-title":"Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes","volume":"29","author":"He","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109709_bb0100","doi-asserted-by":"crossref","first-page":"25011","DOI":"10.1021\/acs.jmedchem.5c01943","article-title":"Design, synthesis and biological evaluation of novel, potent, selective and orally available DGK\u03b1 inhibitors for the treatment of Tumors","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","article-title":"Proteolysis targeting chimeras (PROTACs) in \u2018beyond rule-of-five\u2019 chemical space: recent progress and future challenges","volume":"29","author":"Edmondson","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109709_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104748","article-title":"Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2","volume":"136","author":"Mujwar","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.109709_bb0115","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.jmedchem.3c01093","article-title":"Discovery of novel Aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung Cancer","volume":"67","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0120","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/D2SC06860E","article-title":"Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold","volume":"14","author":"Liu","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109709_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114860","article-title":"Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors","volume":"245","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0130","series-title":"Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters, Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, SC\u201906","author":"Bowers","year":"2006"},{"key":"10.1016\/j.bioorg.2026.109709_bb0135","series-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","first-page":"43","author":"Bowers","year":"2007"},{"key":"10.1016\/j.bioorg.2026.109709_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.comptc.2023.114131","article-title":"Molecular dynamics simulation of the inhibition mechanism of factor XIa by Milvexian-like macrocyclic inhibitors","volume":"1225","author":"Li","year":"2023","journal-title":"Comput. Theor. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.909111","article-title":"3D-QSAR-based pharmacophore modeling, virtual screening, and molecular dynamics simulations for the identification of spleen tyrosine kinase inhibitors","volume":"12","author":"Kumar","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109709_bb0150","first-page":"1","article-title":"Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation","author":"Er-rajy","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109709_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141253","article-title":"Investigating the effect of functionalized carbon nanotube with COOH group on the drug delivery process of doxorubicin in capillary networks around cancer tumors using molecular dynamics simulation","volume":"1328","author":"Zhao","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109709_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238287","article-title":"Computational bioprospecting Guggulsterone against ADP Ri-2 bose phosphatase of SARS-CoV-2","author":"Kciuk","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109709_bb0165","article-title":"Indene-derived hydrazides targeting acetylcholinesterase enzyme in Alzheimer\u2019s: design, synthesis, and biological evaluation","volume":"15","author":"Gupta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109709_bb0170","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/cber.19640971220","article-title":"Untersuchungen \u00fcber die Reaktionsf\u00e4higkeit von Formamidinen, Dimethylformamid-di\u00e4thylacetal (Amidacetal) und bis-dimethyl-amino-methoxy-methan (Aminalester)","volume":"97","author":"Bredereck","year":"1964","journal-title":"Chem. Ber."},{"key":"10.1016\/j.bioorg.2026.109709_bb0175","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0960-894X(96)00197-7","article-title":"Phenylamino-pyrimidine (PAP) \u2014 derivatives: a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors","volume":"6","author":"Zimmermann","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109709_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115892","article-title":"Preparation of novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides and their experimental and computational biological studies","volume":"23","author":"Kciuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109709_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28207230","article-title":"Synthesis, computational, and anticancer in vitro investigations of Aminobenzylnaphthols derived from 2-Naphtol, Benzaldehydes, and \u03b1-Aminoacids via the Betti Reaction","volume":"28","author":"Kciuk","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109709_bb0190","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.3390\/cancers15184442","article-title":"In vitro and in silico investigation of BCI anticancer properties and its potential for chemotherapy-combined treatments","volume":"15","author":"Marciniak","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bioorg.2026.109709_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/2156587214533346","article-title":"Medicinal plants in light of history: recognized therapeutic modality","volume":"19","author":"Khan","year":"2014","journal-title":"J. Evid. Based. Complementary Altern. Med."},{"key":"10.1016\/j.bioorg.2026.109709_bb0200","doi-asserted-by":"crossref","DOI":"10.2174\/187152012803833026","article-title":"Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability","volume":"12","author":"Wang","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0205","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1021\/ja204075s","article-title":"Computer review of ChemDraw ultra 12.0","volume":"133","author":"Cousins","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109709_bb0210","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1021\/ja0410237","article-title":"ChemDraw ultra 9.0. CambridgeSoft, 100 CambridgePark drive, Cambridge, MA 02140. www. cambridgesoft.com. See web site for pricing options","volume":"127","author":"Cousins","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109709_bb0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109709_bb0220","first-page":"469","article-title":"Analysis of cell viability by the MTT assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.bioorg.2026.109709_bb0225","first-page":"315","article-title":"Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase","volume":"4","author":"Mughal","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.bioorg.2026.109709_bb0230","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","article-title":"Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study","volume":"111","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.109709_bb0235","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","article-title":"Clinical pharmacokinetics of imatinib","volume":"44","author":"Peng","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bioorg.2026.109709_bb0240","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal Tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109709_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228010","article-title":"Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples","volume":"15","author":"Hofmanov\u00e1","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.109709_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.35","article-title":"Epigenetic and genetic features of 24 colon cancer cell lines","volume":"2","author":"Ahmed","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bioorg.2026.109709_bb0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/jm049546c","article-title":"Acid-base profiling of imatinib (Gleevec) and its fragments","volume":"48","author":"Szak\u00e1cs","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109709_bb0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00280-008-0730-x","article-title":"Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults","volume":"63","author":"Menon-Andersen","year":"2009","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:53:57Z","timestamp":1774860837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S0045206826002452"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109709","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel phenylamino pyrimidine derivatives as potent and selective inhibitors of ABL1 tyrosine kinase for targeted anticancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109709"}}